PEX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.750400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.972200E-01
Normal-vs-Stage2
8.203000E-01
Normal-vs-Stage3
1.480970E-01
Normal-vs-Stage4
4.563200E-01
Stage1-vs-Stage2
3.849800E-01
Stage1-vs-Stage3
1.333520E-02
Stage1-vs-Stage4
6.761400E-01
Stage2-vs-Stage3
1.6810000058598E-09
Stage2-vs-Stage4
2.562200E-01
Stage3-vs-Stage4
2.392400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.511400E-01
Normal-vs-AfricanAmerican
9.209200E-01
Normal-vs-Asian
8.698400E-01
Caucasian-vs-AfricanAmerican
6.628400E-01
Caucasian-vs-Asian
5.773000E-01
AfricanAmerican-vs-Asian
9.121600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.753400E-01
Normal-vs-Female
8.847200E-01
Male-vs-Female
9.124200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.452400E-01
Normal-vs-Age(41-60Yrs)
8.669600E-01
Normal-vs-Age(61-80Yrs)
7.724600E-01
Normal-vs-Age(81-100Yrs)
5.833600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.515200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.100000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.220600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.072790E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.347400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.676200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.462800E-01
Normal-vs-Daily Drinker
5.947000E-01
Normal-vs-Weekly Drinker
5.117800E-01
Normal-vs-Occasional Drinker
7.241200E-01
Normal-vs-Social Drinker
8.461400E-01
Non Drinker-vs-Daily Drinker
8.733600E-01
Non Drinker-vs-Weekly Drinker
6.531600E-01
Non Drinker-vs-Occasional Drinker
1.027380E-01
Non Drinker-vs-Social Drinker
3.145800E-01
Daily Drinker-vs-Weekly Drinker
7.642200E-01
Daily Drinker-vs-Occasional Drinker
9.831600E-02
Daily Drinker-vs-Social Drinker
2.810600E-01
Weekly Drinker-vs-Occasional Drinker
9.579700E-02
Weekly Drinker-vs-Social Drinker
2.308400E-01
Occasional Drinker-vs-Social Drinker
8.906200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.186380E-01
Normal-vs-Grade 2
7.646400E-02
Normal-vs-Grade 3
2.804200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.929000E-01
Grade 1-vs-Grade 3
5.312000E-01
Grade 1-vs-Grade 4
1.186380E-01
Grade 2-vs-Grade 3
6.754000E-01
Grade 2-vs-Grade 4
7.646400E-02
Grade 3-vs-Grade 4
2.804200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.715200E-01
Normal-vs-NonDiabetic
9.487200E-01
Diabetic-vs-NonDiabetic
7.654200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.358400E-01
Normal-vs-NoPancreatitis
8.370600E-01
Pancreatitis-vs-NoPancreatitis
5.586600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.666200E-01
Normal-vs-N1
8.037200E-01
N0-vs-N1
5.037000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.619800E-01
Normal-vs-TP53-NonMutant
6.433800E-01
TP53-Mutant-vs-TP53-NonMutant
4.122400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
